摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N1-(1-丙基-1H-苯并咪唑-2-基)-1,3-苯二甲酰胺 | 1111556-37-6

中文名称
N1-(1-丙基-1H-苯并咪唑-2-基)-1,3-苯二甲酰胺
中文别名
——
英文名称
takinib
英文别名
N-(1-propyl-1H-benzo[d]imidazol-2-yl)isophthalamide;3-N-(1-propylbenzimidazol-2-yl)benzene-1,3-dicarboxamide
N1-(1-丙基-1H-苯并咪唑-2-基)-1,3-苯二甲酰胺化学式
CAS
1111556-37-6
化学式
C18H18N4O2
mdl
——
分子量
322.367
InChiKey
UOZVVPXKJGOFIG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    90
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • CELL AGGREGATION INCLUDING OLFACTORY NEURON OR PRECURSOR CELL THEREOF, AND METHOD FOR PRODUCING SAME
    申请人:SUMITOMO CHEMICAL COMPANY LIMITED
    公开号:EP3842527A1
    公开(公告)日:2021-06-30
    A method for producing a cell cluster including an olfactory receptor neuron or a precursor cell thereof, comprising the following steps (1) to (3): step (1) of suspension-culturing a pluripotent stem cell in the presence of a Wnt signaling pathway inhibitory substance to form a cell aggregate; step (2) of suspension-culturing the cell aggregate obtained in the step (1) in the presence of a BMP signaling pathway-activating substance; and step (3) of suspension-culturing the cell aggregate obtained in the step (2) to obtain the cell cluster, wherein step (3) comprises at least one step selected from the group consisting of: step (3a) of suspension-culturing in the presence of an FGF signaling pathway-activating substance; step (3b) of suspension-culturing in the presence of a BMP signaling pathway inhibitory substance; and step (3c) of culturing in the presence of an FGF signaling pathway-activating substance and a BMP signaling pathway inhibitory substance.
    一种生产包括嗅觉受体神经元或其前体细胞的细胞团的方法,包括以下步骤(1)至(3):步骤(1)在Wnt信号通路抑制物质存在下悬浮培养多能干细胞以形成细胞聚集体;步骤(2)在BMP信号通路激活物质存在下悬浮培养步骤(1)中获得的细胞聚集体;以及步骤(3)悬浮培养步骤(2)中获得的细胞聚集体以获得细胞簇,其中步骤(3)包括至少一个选自由以下组成的组的步骤:在 FGF 信号通路激活物质存在下进行悬浮培养的步骤(3a); 在 BMP 信号通路抑制物质存在下进行悬浮培养的步骤(3b);以及 在 FGF 信号通路激活物质和 BMP 信号通路抑制物质存在下进行培养的步骤(3c)。
  • Substituted benzimidazole and substituted benzothiazole inhibitors of transforming growth factor-β kinase and methods of use thereof
    申请人:Duke University
    公开号:US10207998B2
    公开(公告)日:2019-02-19
    The present invention provides novel inhibitors of TAK1 having formula (I) and methods of using such compounds to treat various diseases.
    本发明提供了具有式(I)的新型 TAK1 抑制剂以及使用此类化合物治疗各种疾病的方法。
  • Substituted benzimidazoles as inhibitors of transforming growth factor-β kinase
    申请人:Duke University
    公开号:US10927083B2
    公开(公告)日:2021-02-23
    The present invention provides inhibitors of TAK1 having formula (II), affinity resins, and fluorescent dyes and methods of using such compounds to treat various diseases or in protein isolation or purification.
    本发明提供了具有式(II)的 TAK1 抑制剂、亲和树脂和荧光染料,以及使用此类化合物治疗各种疾病或分离或纯化蛋白质的方法。
  • SUBSTITUTED BENZIMIDAZOLE AND BENZOTHIAZOLE INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA KINASE AND METHODS OF USE THEREOF
    申请人:Duke University
    公开号:US20190263759A1
    公开(公告)日:2019-08-29
    The present invention provides inhibitors of TAK1 having formula (II), affinity resins, and fluorescent dyes and methods of using such compounds to treat various diseases or in protein isolation or purification.
  • SUBSTITUTED BENZIMIDAZOLES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA KINASE
    申请人:Duke University
    公开号:US20210188783A1
    公开(公告)日:2021-06-24
    The present invention provides inhibitors of TAK1 having formula (II), affinity resins, and fluorescent dyes and methods of using such compounds to treat various diseases or in protein isolation or purification.
查看更多